Valuation: Cegedim

Market Cap 139M 160M 129M 119M 224M 15.23B 227M 1.52B 597M 7.58B 599M 586M 25.42B P/E 2026 *
6.62x
P/E 2027 * 5.05x
Enterprise Value 301M 346M 280M 257M 485M 33.04B 493M 3.3B 1.3B 16.45B 1.3B 1.27B 55.15B EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.4x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-0.39%
1 month-5.61%
3 months-15.83%
6 months-24.34%
Current year-25.46%
1 week 9.95
Extreme 9.95
10.36
1 month 9.95
Extreme 9.95
10.6
Current year 8.5
Extreme 8.5
15.3
1 year 8.5
Extreme 8.5
15.3
3 years 8.5
Extreme 8.5
21.8
5 years 8.5
Extreme 8.5
29.8
10 years 8.5
Extreme 8.5
44.5
Manager TitleAgeSince
Chief Executive Officer 83 2009-10-24
Director of Finance/CFO - 2016-06-13
Corporate Officer/Principal 55 2015-11-25
Director TitleAgeSince
Chairman 83 2009-10-24
Director/Board Member 72 2010-08-08
Director/Board Member 55 2009-10-25
Date Insider Type Main position Quantity % Market Cap.
4/16/26 Buy 500 0.0035%
3/5/26 Buy 1,517 0.0108%
3/3/26 Buy 121,659 0.8630%
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-.--%-7.34%-52.80% 160M
+1.81%+12.94%-48.82%+10.78% 374B
+1.13%+12.47%-37.13%+26.75% 209B
+1.05%+12.60%-41.03%-4.61% 115B
-0.56%+12.59%-37.18%+7.79% 45.36B
-4.56%+1.76%-76.79%+113.03% 35.87B
-1.45%-9.25%-21.84%+34.01% 24.25B
-1.77%+11.12%-33.93%+46.22% 18.71B
-0.84%+6.94%-32.55%+5.17% 13.19B
-0.83%+9.92%-32.84%+79.13% 12.65B
Average -0.90%+7.11%-36.94%+26.55% 84.86B
Weighted average by Cap. -0.27%+11.47%-43.84%+19.16%

Financials

2026 *2027 *
Net sales 660M 759M 614M 564M 1.06B 72.43B 1.08B 7.24B 2.84B 36.06B 2.85B 2.79B 121B 684M 787M 637M 585M 1.1B 75.12B 1.12B 7.51B 2.95B 37.4B 2.96B 2.89B 125B
Net income 21.3M 24.5M 19.83M 18.2M 34.37M 2.34B 34.91M 234M 91.72M 1.16B 92.02M 90M 3.9B 28M 32.21M 26.06M 23.93M 45.19M 3.07B 45.89M 307M 121M 1.53B 121M 118M 5.13B
Net Debt 162M 187M 151M 139M 262M 17.81B 266M 1.78B 698M 8.86B 701M 685M 29.72B 134M 154M 124M 114M 216M 14.69B 219M 1.47B 576M 7.31B 578M 565M 24.52B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
26-07-31 €10.10 -0.39% 697
26-07-30 €10.14 +0.20% 5,686
26-07-29 €10.12 -0.78% 7,749
26-07-28 €10.20 +0.59% 1,026
26-07-27 €10.14 +0.40% 3,806
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.10EUR
Average target price
15.50EUR
Spread / Average Target
+53.47%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCGM Stock